![Xinhua Zhao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xinhua Zhao
Plus aucun poste en cours
Historique de carrière de Xinhua Zhao
Anciens postes connus de Xinhua Zhao
Sociétés | Poste | Début | Fin |
---|---|---|---|
TERRAVIA HOLDINGS INC | Directeur Technique/Scientifique/R&D | 14/05/2012 | - |
Corporate Officer/Principal | 01/03/2010 | 14/05/2012 | |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Analyste en capital-investissement | - | 04/02/2010 |
Corporate Officer/Principal | 04/02/2010 | - |
Formation de Xinhua Zhao
Purdue University | Doctorate Degree |
Zhejiang University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Chine | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Private Equity Analyst | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
TerraVia Holdings, Inc.
![]() TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables TerraVia Holdings, Inc. engaged in the production of food, nutrition, and specialty ingredients from algae. It produced oils, specialty fats, and powdered ingredients using its microalgae-based technology platform. The company was founded by Jonathan S. Wolfson and Harrison F. Dillon on March 31, 2003 and was headquartered in San Francisco, CA. | Consumer Non-Durables |
AureoGen, Inc.
![]() AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Health Technology |
- Bourse
- Insiders
- Xinhua Zhao
- Expérience